CISO Global 3Q 2026: Revenue $5.62M, EPS ($0.07) — 10-Q Summary

CISO Global reported 3Q 2026 revenue of $5.62M, down 13% YoY, and a net loss of $3.14M, compared to a profit a year ago. The decline was driven by lower security managed services revenue from lost customers, partly offset by growth in cybersecurity software. The company also recorded a $1.7M goodwill impairment charge.

Original reporting
Published Nov 13, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CISO Global 3Q 2026: Revenue $5.62M, EPS ($0.07) — 10-Q Summary — source image
Decision brief

The 30-second read

$CISOBearishMed
01

Why it matters

The earnings miss and goodwill impairment suggest short‑term downside risk, but software license growth offers a possible upside catalyst.

02

Market read

The report provides fresh financial data for a micro‑cap cybersecurity stock, likely prompting immediate price action.

03

What to watch

Potential cost‑cutting measures and new engagements could improve margins in the next quarter.

Relevance 6/10Novelty 6/10Timing: after‑hours reaction

Background

CISO Global is a small cybersecurity services provider that filed its Q3 2026 10‑Q.

Company-level read

Ticker impact

$CISOBearishHigh confidence
Context

CISO Global reported Q3 2026 revenue of $5.62M, a 13% YoY decline and a loss of $3.14M, including a $1.7M goodwill impairment.

Expected impact

downward pressure as investors price in the loss and goodwill charge

Evidence & confidence

The company posted a surprise loss and a material goodwill impairment, which historically trigger sell‑offs in micro‑caps.

Market effects

Highlights weakness in the managed‑services segment of the cybersecurity sector.

Primarily affects U.S. micro‑cap investors; limited broader regional effect.

Minimal global impact; confined to niche cybersecurity services market.

Counterpoint

If the software license growth sustains, the loss may be temporary and the stock could rebound.

Key entities

  • CISO Global, Inc.

    Cybersecurity services firm reporting Q3 2026 results.

Related articles

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

$YTRAMed

Yatra Online Inc (YTRA) (Q2 2027) Earnings Call Highlights: Air and Corporate Travel

Yatra Online (YTRA) reported Q2 2027 revenue from operations down 39% YoY to INR2,136M (~$22M) due to lower MICE volumes. Gross margin stayed flat at INR1,255M (~$13M). Adjusted EBITDA swung to negative INR32M (~negative $0.3M). CEO Gupta noted MICE recovery signs, TravelPro and Recap initiatives progress, and AI efficiency gains. Standalone hotels grew 20% YoY. H1 FY27 revenue declined 28% YoY to INR4,015M (~$42M).

$PARKHighAI 8/10

Park Dental Partners Inc (PARK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 6%

Park Dental Partners Inc (PARK) reported Q3 2026 revenue of $64.9M, up 6% YoY, driven by acquisitions and clinical hours. The company acquired Village Family Dental for $39.1M, funded with cash, a small credit line draw, and stock. PARK updated its 2026 revenue outlook to $262M-$265M and adjusted EBITDA to $21.2M-$22.2M. Gross margin declined due to higher salaries and cybersecurity costs. The acquisition adds 47 doctors and expands PARK's footprint to North Carolina.